Niagen Bioscience, Inc. (NAGE) vs Cartesian Therapeutics, Inc. (RNAC)
Niagen Bioscience, Inc. and Cartesian Therapeutics, Inc. are both Biotechnology companies. Niagen Bioscience, Inc. and Cartesian Therapeutics, Inc. are of similar size ($238.2M and $230.6M). Cartesian Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. Niagen Bioscience, Inc. grew revenue faster over the last twelve months: 11.0% against −94.8%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs 0.00%) and the higher return on invested capital (42.0% vs 0.00%). Across the 17 metrics below, Niagen Bioscience, Inc. leads on 13 and Cartesian Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | NAGE | RNAC | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.24% | 100.00% | 65.16% |
| Operating margin | 8.21% | 0.00% | 0.00% |
| Net margin | 12.39% | 0.00% | 0.00% |
| Free cash flow margin | 8.89% | 0.00% | 0.00% |
| Return on equity | 21.80% | 236.88% | (57.72%) |
| Return on assets | 16.14% | (42.77%) | (49.22%) |
| Return on invested capital | 41.95% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack